Common use of Medical Devices Clause in Contracts

Medical Devices. In the period 2004 to 2005, the medical device manufacturing and development industry consisted of 1’101 facilities, comprising approximately 998 firms. Medical device manufacturing and development facilities were generally small as more than half (57%) had fewer than 25 employees and 37% had from 25 to 49 employees. Of the remaining facilities, only 45 (4%) were of medium size (50-150 employees), and less than 1% were large (greater than 150 employees). Approximately 90% of the medical device facilities were Canadian owned, unchanged from 2002. Foreign-owned facilities tended to be larger as 21% had 50 or more employees, compared to just 4% of domestically-owned facilities. 42% of the medical device industry is located in Ontario, 32% in Quebec. Canada’s exports of medical devices increased at a solid compound annual growth rate of 10.5% from 2000 to 2005. The country’s nearly 1'000 medical devices manufacturing and development firms generated sales of CND 4 bn in 2003, with exports representing 52% of total sales. The US market accounted for 76% of all exports in 2005, followed by the UK (4%), Germany (3%) and China (2%). Leading medical device companies as Baxter, 3M, Bard, McKesson, St. Jude, Siemens, Mitroflow and Tyco have invested in Canada. As Industry Canada states, they have capitalized on low costs, generous R&D incentives and a progressive regulatory regime. Under the Food and Drugs Act, Health Canada defines a device as "any article, instrument, apparatus or contrivance, including any component, part or accessory thereof, manufactured, sold or represented for use in:

Medical Devices. In the period 2004 to 2005, the medical device manufacturing and development industry consisted of 1’101 facilities, comprising approximately 998 firms. Medical device manufacturing and development facilities were generally small as more than half (57%) had fewer than 25 employees and 37% had from 25 to 49 employees. Of the remaining facilities, only 45 (4%) were of medium size (50-150 employees), and less than 1% were large (greater than 150 employees). Approximately 90% of the medical device facilities were Canadian owned, unchanged from 2002. Foreign-owned facilities tended to be larger as 21% had 50 or more employees, compared to just 4% of domestically-owned facilities. 42% of the medical device industry is located in Ontario, 32% in Quebec. Canada’s exports of medical devices increased at a solid compound annual growth rate of 10.5% from 2000 to 2005. The country’s nearly 1'000 medical devices manufacturing and development firms generated sales of CND 4 bn in 2003, with exports representing 52% of total sales. The US market accounted for 76% of all exports in 2005, followed by the UK (4%), Germany (3%) and China (2%). Leading medical device companies as BaxterXxxxxx, 3M, Bard, McKesson, St. Jude, Siemens, Mitroflow and Tyco have invested in Canada. As Industry Canada states, they have capitalized on low costs, generous R&D incentives and a progressive regulatory regime. Under the Food and Drugs Act, Health Canada defines a device as "any article, instrument, apparatus or contrivance, including any component, part or accessory thereof, manufactured, sold or represented for use in: